Word

MERISTEM THERAPEUTICS

Status

Dead

Status Code

710

Status Date

Friday, May 25, 2012

Serial Number

75557320

Registration Number

2499316

Registration Date

Tuesday, October 23, 2001

Mark Type

3000

Filing Date

Wednesday, September 23, 1998

Published for Opposition

Tuesday, July 31, 2001

Cancellation Date

Friday, May 25, 2012

Trademark Owner History

MERISTEM THERAPEUTICS -
BIOCEM - Original Registrant

Classifications

1 [ Chemicals for use in the manufacture of photographic materials, namely, dyes, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, cosmetics, glues and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil conditioners, fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, and proteins, namely, plant and animal and microbial growth hormones, growth regulators and inhibitors, diagnostic regents, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers ]

3 [ Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or immunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and celluloses, all obtained from plants ]

5 [ Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies ]

42 Scientific and industrial research, namely, biotechnology research on chemical products intended for industry, science, photography, agriculture, horticulture, forestry, on pharmaceutical or cosmetic proteins obtained from plants, on pharmaceutical products, veterinary products, hygiene products within the pharmaceutical field, on dietary products for children, on biotechnology products obtained from plants; biological and biotechnological services, namely, genetic modification of plants and plant cells, embryos, cals, seeds, pollen leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, and field trials of genetically modified plants; expression of therapeutic, cosmetic or nutritional proteins or protein fragments through genetic modification, regeneration, and reproduction of plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biotechnology laboratories; engineering work and research and development in plant biotechnology

"THERAPEUTICS"
THE WORD "MERISTEM" IN THE MARK APPEARS IN BLUE, THE WORD "THERAPEUTICS" IN THE MARK APPEARS IN GREEN, THE GRAPHIC ON THE FAR LEFT OF THE MARK CONTAINING THE STYLIZED BRANCH DEPICTION IS A COLORLESS BRANCH ON A GREEN BACKGROUND WITH A DARKER GREEN SHADOW APPEARING UNDER THE BRANCH, THE CIRCULAR GRAPHIC IN THE CENTER OF THE MARK CONTAINING THE STYLIZED DNA DEPICTION IS A COLORLESS HELICAL DESIGN ON A BLUE BACKGROUND WITH A DARKER BLUE SHADOW APPEARING UNDER THE HELICAL DESIGN, AND THE GRAPHIC APPEARING AT THE RIGHT OF THE MARK CONTAINING THE STYLIZED HUMAN FIGURE IS A COLORLESS HUMAN FIGURE ON A LIGHT ORANGE BACKGROUND WITH A RED SHADOW APPEARING UNDER THE HUMAN FIGURE.

Trademark Events

May 25, 2012

Cancelled Sec. 8 (10-Yr)/Expired Section 9

May 12, 2008

Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.

Apr 23, 2008

Registered - Sec. 8 (6-Yr) & Sec. 15 Filed

May 6, 2008

Assigned To Paralegal

Apr 23, 2008

Teas Section 8 & 15 Received

Apr 23, 2008

Automatic Update Of Assignment Of Ownership

Jan 18, 2007

Case File In Ticrs

Oct 23, 2001

Registered-Principal Register

Jul 31, 2001

Published For Opposition

Jul 18, 2001

Notice Of Publication

Feb 14, 2001

Approved For Pub - Principal Register

Sep 22, 2000

Correspondence Received In Law Office

Mar 31, 2000

Final Refusal Mailed

Nov 15, 1999

Correspondence Received In Law Office

Oct 11, 1999

Assigned To Examiner

Jun 21, 1999

Non-Final Action Mailed

May 13, 1999

Non-Final Action Mailed

Apr 29, 1999

Assigned To Examiner

Apr 23, 1999

Assigned To Examiner